Research & Development: Page 48
-
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
Talent Pool
Talent Pool By Ann Grey Pharma Pool Dave Lemus Sigma-Tau Pharmaceuticals Names CEO Sigma-Tau Pharmaceuticals Inc. has promoted Dave Lemus to the newly created position of CEO. Mr. Lemus had served as chief operating officer of the company since March 2012 and he joined the company as VP of financ...
By Ann Grey • July 29, 2013 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
On the Calendar
August 5, Medicare Chronic Care Pre-Conference Workshop Hyatt Regency Orange County, Garden Grove, Calif. Opal Events, http://www.opalevents.org/p/92/medicare-chronic-care-pre-conference-workshop August 5-7 Active Pharmaceutical Ingredient (API) and Drug Product Specifications The Hilton Los Ange...
By PharmaVoice Team • July 29, 2013 -
PharmaTrax
Trending Now: Payer approaches to specialty drugs reveal innovation and experimentation as payers navigate this dynamic healthcare marketplace. Ensuring the appropriate use of specialty drugs is a major priority for health plans today and will become increasingly important for their future growth...
By Denise Myshko • July 29, 2013 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Sunshine Act Compliance MMIS Launches Spend Solution for Smaller Companies E-UPGRADES Veeva Systems Introduces Customer Master Solution Tools of the Trade Trending Now: Software-as-a-service solution provides cus...
By Denise Myshko • July 29, 2013 -
2013 PharmaVOICE 100 - Who's on the List by Company
2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...
By Taren Grom • July 29, 2013 -
Letter from the Editor
Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...
By Taren Grom • July 29, 2013 -
Take the Express Toward NDA Approval
Pharmaceutical manufacturers spend on average $1 billion developing a product for commercialization. With this tremendous investment, it is a pharmaceutical developer’s nightmare to have its product fail during the New Drug Application (NDA) filing process due to safety concerns or lack of pharma...
By Michael O'Gorman • May 29, 2013 -
Defining Innovation Differently
Innovation, it seems, is the buzzword in every business strategy plan. It’s what pharmaceutical training has always taught us to aspire to. We all want to stay ahead of the curve. And yet, like most of the words in the dictionary, how many ideas are truly new? How many are truly innovative? Well,...
By Mark A. Lanfear • May 29, 2013 -
Successful Strategic Partnering
Urgent and competing demands are challenging the clinical development efforts of today’s biopharmaceutical companies. Pressures to enhance innovation, feed pipelines, and improve efficiency and quality, all while lowering costs in an evolving regulatory environment are more acute than ever before...
By Brenda Hoeper • May 29, 2013 -
Maximizing Speed to Market by Empowering the Human Element
Under greater public scrutiny in an increasingly environmentally conscious world, Dow Chemical launched a new advertising campaign in 2008 to demystify the people behind the science of the products it developed. This award-winning campaign, called “the Human Element," featured stunning photos of ...
By Michael R. Waldman • May 29, 2013 -
Can We Make Monitoring Better? That's the $5 Billion Question.
Incredibly, only 6 percent of new pharmaceutical products ever recoup their development costs. Any other industry would simply cease production of such an unprofitable venture. But we don’t have that luxury. We need to change the way we do things and reduce resource-sapping redundancies. And that...
By Amy Kissam • May 29, 2013 -
This Old House: Conducting A Clinical Trial Energy Audit
Our local utility company offers free “energy audits." An auditor will check the robustness of your heating, ventilation, and air conditioning (HVAC) systems and examine your home’s physical envelope — walls, floors, windows, doors — to assess it for leaks. When you live in New England (cold wint...
By Denise Derenzo Lacey • May 29, 2013 -
Clinical Transformation: More Than A Solution It's A New Way To Work
To succeed in today’s global competitive market, drug companies need to innovate and pursue efficient ways of conducting clinical trials to shorten cycle times and achieve cost savings. As an answer to these new challenges, companies need an integrated and holistic solution based on process optim...
By Bhaskar Sambbasivan • May 29, 2013 -
Artificial Intelligence Improves Pharma Efficiency
As I consult with clients, I see that technology will ultimately be the driver behind pharmaceutical and biotechnology advancements in the coming decade. I believe that the use of artificial intelligence (AI) is a prime example of innovative efficiencies to come. More than 15 years ago, when I wa...
By G. Steven Geis • May 29, 2013 -
Monitoring Cardiac Safety: Minimizing Risk For Your Next Clinical Trial
Many drugs used to treat non-cardiac conditions are known to have off-target cardiovascular effects including arrhythmias, hypertension, and reduced ventricular function, which may lead to increased cardiac risk and possibly death. This presents a major challenge not only for clinicians who admin...
By Mark Weinstein • May 29, 2013 -
Electronic Patient Reported Outcomes and Integrated Systems: Effective Solutions for Enhanced Compliance and High Data Quality
With all the elements that comprise a clinical trial — from design to enrollment to analysis — it is little wonder that success can be impeded by challenges along the way. Use of Electronic Patient Reported Outcome Technologies Low patient compliance and low data quality of Patient Reported Outco...
By Valarie Higgins • May 29, 2013 -
Innovative Israel Creates Pharma Opportunity
The state of Israel is one of the most advanced economies in the southwest Asia region, and is rated 38th out of 185 nations worldwide on the World Bank’s Ease of Doing Business Index. Often described as a start-up nation, Israel hosts more NASDAQ-listed companies per citizen than any other count...
By Kim Ribbink • May 29, 2013 -
2013 DIA Preview
2013 DIA Preview This year’s theme: Advancing Therapeutic Innovation and Regulatory Science. The Drug Information Association’s 49th Annual Meeting will be held June 23 to 27 at the Boston Convention & Exhibition Center. There will be more than 250 sessions covering 22 tracks on hot topics fr...
By Taren Grom • May 29, 2013 -
Adapting to Adaptive Drug Development
The promise of cost-savings associated with adaptive clinical trials is an attractive one. Many drug companies have already put in place trials that use some type of adaptive designs. But most times, companies implement adaptive trial design experimentally, mitigating risk by applying it only dur...
By Denise Myshko • May 29, 2013 -
Last Word
Global Trade Organization Amplifies Sites’ Voice Christine pierre, President of RxTrials, takes the helm of the Society for Clinical Research Sites (SCRS) after forming the organization to help sites raise their voice with sponsors, CROs, and other clinical stakeholders. The LAST Word PV: What wa...
By Christine Pierre • May 29, 2013 -
Talent Pool
Pharma Pool Dr. Lynn KRAMER Eisai Creates New Chief Clinical Officer Position Eisai, the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., has appointed Lynn Kramer, M.D., to the newly created position of chief clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer is respo...
By Ann Grey • May 29, 2013 -
On the Calendar
June 17-18 Gross to Net Accounting Forum for Pharmaceutical Manufacturers Hyatt Harbor Side, Boston Institute for International Research, iirusa.comJune 17-19 Next-Gen Kinase Inhibitors The Revere Hotel, Boston Cambridge Healthtech Institute, healthtech.com/kin/ June 18 5th Annual Cloud Slam 2013...
By Heather Hummel • May 29, 2013 -
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: GSW Launches Health Experience Project Teva Establishes Global Specialty Medicines Group Sidebars: On the Shelves AROUND THE GLOBE New 360 Corporate Compliance Program for the Life-Sciences Industry Weber Shandwick Launch...
By Ann Grey • May 29, 2013 -
PharmaTrax
Pharma Trax Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Strategic Partnerships Provide Value Engaging Digital Patients Can Foster Biopharma Product Development Use of Digital Marketing Channels to Increase Sidebars: Impact of Strategic Partnerships Key Findings in...
By Denise Myshko • May 29, 2013